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A personalised approach to therapy is hoped to improve
Oesophageal cancer survival rates. Recently, the inclusion of
radiomic features extracted from PET images into prognostic
models has gained substantial interest. However, radiomic
features are dependent on the target volume definition (TVD) [1].
Many automatic PET segmentation methods (PET-AS) exist and are
regularly used for feature extraction.
Introduction
The aim of this study is to investigate the dependency of patient
risk stratification on TVD, defined by different PET-AS, when
prognostic models are developed with radiomic features.
Aims & Objectives
Consecutive patients (n=427) with biopsy-proven Oesophageal
cancer staged with PET/CT were included. Patients received
4MBq/kg of 18F-FDG before image acquisition at 90 minutes. In
each case, the Metabolic Tumour Volume (MTV) was defined using
Clustering Means (KM2), General Clustering Means (GCM3),
Adaptive Thresholding (AT) and Watershed Thresholding (WT) PET-
AS. Table 1, describes PET-AS implementations. All tumour
segmentations were reviewed by a radiologist to ensure accuracy.
Prognostic models using identical clinical data but different
radiomic features defined by each segmentation method were
developed. Changes in patient classification between risk groups
were analysed. A p-value of <0.05 was considered statistically
significant. Primary outcome was overall survival (OS).
Materials & Methods
Results
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The equations for each model from different segmentation methods are
listed in Table 2. Age, treatment and radiological stage were significant
variables in all prognostic models. Skewness was a significant variable in
GCM3 and WT based models. Table 3 shows the number (percentage) of
patients that changed risk stratification between developed prognostic
models. Figure 1 shows the overall survival for the KM2, GCM3, AT and
WT developed models. There was no significant difference in median OS
between KM2, GCM3, AT and WT low-risk groups (P > 0.5), intermediate-
risk (P > 0.5) and high-risk groups OS (P > 0.5).
Radiomic features are dependent on the PET-AS used and consequently influence patient risk stratification when incorporated into
prognostic models. Methods used to define the metabolic tumour volume in PET radiomic studies should be standardised.
Table 3: Number of patients changing risk stratification between prognostic models
Number of patients changing risk 
stratification
(%)
AT based prognostic 
model
GCM3 based 
prognostic
model
KM2 based prognostic 
model
GCM3 based prognostic model 66 (15.4)
KM2 based prognostic model 0 (0.0) 66 (15.4)
WT based prognostic model 57 (13.3) 73 (17.1) 57 (13.3)
Figure 1 Risk stratification and OS for WT (Top Left), KM2 (Top Right), AT (Bottom Left), GCM3 
(Bottom Right).
Algorithm Description
AT
3D Adaptive iterative thresholding, using background 
subtraction
RG
3D Region-growing with automatic seed finder and 
stopping criterion
KM2/KM3
3D K-means iterative clustering with custom stopping 
criterion
FCM2
3D Fuzzy-C-means iterative clustering with custom 
stopping criterion
GCM3/GCM4
3D Gaussian Mixture Models-based clustering with 
custom stopping criterion
WT Watershed Transform–based algorithm, using Sobel filter.
ATLAAS
A decision tree based segmentation methodology 
incorporating individual PET-AS included within this study.
Table 1: Descriptions of PET-AS used to delineate GTVPET.
Segmentation 
Method
Prognostic Model Equation
AT (Age * 0.020) - (Treatment * 1.075) + (Stage * 0.144)
GCM3
(Age * 0.019) - (Treatment * 1.024) + (Stage * 0.142) - (Skewness * 0.789) + (Kurtosis 
* 0.632)
KM2 (Age * 0.020) - (Treatment * 1.075) + (Stage * 0.144)
WT
(Age * 0.018) - (Treatment * 1.063) + (Stage * 0.140) + (Skewness * 0.674) + (GLNU * 
0.017)
Table 2: Equations of models developed from differing PET-AS methods.
Table 3: Number of (percentage) of patients that change risk stratification between models
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